COLGATE PALMOLIVE CO

COLGATE PALMOLIVE CO Annual Report Summary (Fiscal Year Ended December 31, 2024)

Business Overview: Colgate-Palmolive, a global consumer products powerhouse, demonstrated resilience and strategic foresight in 2024. Renowned for its essential brands across Oral Care, Personal Care, Home Care, and Pet Nutrition, the company successfully navigated a dynamic market. It prioritized pricing strategies, rigorous cost management, and targeted investments, all while laying the groundwork for future expansion.

Financial Performance: Colgate-Palmolive delivered strong financial results in fiscal year 2024:

• Net sales reached $19.5 billion, a 4.5% increase from 2023. This growth stemmed mainly from strategic price increases across its product range, which boosted sales by about 6%. A slight 1% volume decline and minimal foreign exchange impact partially offset this.
• Organic sales grew by 5.5%.
• Net income rose 8% year-over-year to $2.8 billion, leading to diluted earnings per share (EPS) of $3.30.
• The ongoing "Global Productivity Initiative" significantly bolstered profitability, expanding the gross margin by 150 basis points to 59.5%.
• Operating profit increased to $3.7 billion.

Segment Performance: All major segments fueled sales growth, with Oral Care and Pet Nutrition (Hill's Science Diet) standing out as particularly strong performers. These segments benefited from robust demand and successful product innovation. The company's overall profitability reflects effective management across these core business areas.

Risk Factors: Colgate navigates various risks, including:

• Intense competition from both established companies and new brands, especially as consumer preferences rapidly change.
• Fluctuations in foreign exchange rates and commodity prices, which remain a key concern despite hedging strategies.
• Challenges in successfully implementing large-scale programs like the SGPP, which could lead to execution issues, operational disruptions, or failure to achieve expected cost savings.
• Broader global economic uncertainties, inflationary pressures, and supply chain disruptions, all of which could affect profitability and growth.
• Potential challenges from regulatory changes concerning product safety, environmental standards, and marketing practices.

Management Discussion (MD&A Highlights): In 2024, Colgate-Palmolive continued its multi-year "Global Productivity Initiative" (GPI), which focused on streamlining operations, optimizing supply chains, and cutting manufacturing costs. This program generated approximately $250 million in annualized savings for the year, substantially boosting margin improvement.

Looking forward, the company unveiled a new "Strategic Growth and Productivity Program" (SGPP), set to begin in 2025. This initiative aims to further enhance efficiency and fuel long-term growth through strategic investments in innovation, digital transformation, and market expansion. The SGPP is expected to incur pre-tax charges of $1.2 billion to $1.5 billion over its lifespan, but it anticipates delivering annualized savings of $300 million to $400 million by 2027.

A key strategic move for the future is the planned acquisition of CareTopCo Pty Ltd in April 2025 for approximately $1.7 billion. This acquisition will expand Colgate's footprint in the premium oral care segment, particularly in high-growth markets, and diversify its product offerings.

Financial Health: Colgate-Palmolive maintains a strong financial position:

• It has access to a robust $3.0 billion revolving credit facility, updated in late 2022, ensuring ample liquidity.
• In early 2025, the company proactively managed its debt by issuing new debt, including 5-year notes at 4.200% interest and 10-year notes at 3.250% interest. These funds will support general corporate purposes, such as potential acquisitions and working capital.
• To reduce financial volatility, Colgate actively uses hedging instruments, like foreign exchange and commodity contracts. This strategy helps manage exposure to currency and raw material price swings, making costs and earnings more predictable.

Future Outlook: Looking ahead to 2025, Colgate-Palmolive projects organic sales growth of 3% to 5% and mid-single-digit adjusted diluted EPS growth. These projections are driven by the new Strategic Growth and Productivity Program and the integration of CareTopCo. The company also remains dedicated to disciplined capital allocation, focusing on brand building, strategic acquisitions, and returning value to shareholders through dividends.

Competitive Position: Colgate-Palmolive strengthens its leading competitive position across core categories by leveraging its strong brand equity and extensive global distribution network. The company focuses on innovation, digital engagement, and sustainability initiatives to meet evolving consumer preferences.